polycystic ovarian syndrome. Polycystic ovarian syndrome
Conditions
Interventions
Intervention 1: Intervention group: Calcium, 1000 mg orally tablets ,twice a day for 2 months, intervention group. Intervention 2: Intervention group:Vitamin D, 400 mg orally Tablets, twice a day for
Treatment - Drugs
Intervention group: Calcium, 1000 mg orally tablets ,twice a day for 2 months, intervention group
Intervention group:Vitamin D, 400 mg orally Tablets, twice a day for 2 months
Intervention group:Zinc, 50 mg orally tablets , once daily for 2 months
Intervention group: Magnesium, 75 mmol oral tablet, once a day for 2 months
Sponsors
Hamadan Univesity of Medical Sciences
Eligibility
Sex/Gender
Female
Age
20 Years to 45 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: Abnormal menstrual cycles, polycystic ovaries in sonography, chemical or clinical signs of hyper androgenism. Exclusion criteria: History of any underlying and chronic disease, history of pelvic or abdominal surgery, partner's infertility, abnormal level of serum prolactin, smoking, current or previous using of statins in last 2 months, insuline usage, corticosteroid usage, history of neoplastic disease.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heart condition. Timepoint: 2 months after intervention. Method of measurement: Echocardiography. | — |
Secondary
| Measure | Time frame |
|---|---|
| Serum lipids level. Timepoint: tow months after intervention. Method of measurement: Patients blood sampel.;Serum insullin level. Timepoint: tow months after intervention. Method of measurement: Patients blood samples patients. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactRoghaieh Anvari
Hamadan University of Medical Sciences
Outcome results
None listed